China Medical GatewayLoading your healthcare gateway…

Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS)

Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS) — Beijing

Hospital Profile

The Cancer Hospital of the Chinese Academy of Medical Sciences was founded in 1958 (originally named Ritan Hospital). It is a tertiary A-level cancer specialty hospital under the National Health Commission and the first cancer specialty hospital established in New China. It serves as the supporting institution for the National Cancer Center and was among the first batch of "guidance-type" national medical centers, integrating medical treatment, education, research, and prevention. The hospital has 5 national key disciplines and 6 national clinical key specialties. It has consistently ranked first among tertiary cancer specialty hospitals in the national performance evaluation of tertiary public hospitals (Grade A). The hospital has trained eight academicians of the Chinese Academy of Sciences and the Chinese Academy of Engineering, including Wu Min, Lu Shixin, He Jie, Sun Yan, Cheng Shujun, Zhan Qimin, Lin Dongxin, and Xu Binghe, as well as over a hundred other national high-level talents. It has won 26 national-level awards, including 3 first-class National Science and Technology Progress Awards.

Medical Milestones

Founded in 1958; the Institute of Cancer Research was added in 1962; relocated to the Longtan Lake area and renamed in 1983; became the affiliated institution of the National Cancer Center in 2009, with the Institute of Cancer Research incorporated into the National Cancer Center; became one of the first batch of 'guidance-type' National Medical Centers in 2021. Domestically pioneered innovative techniques such as Hmarker precise localization for lung nodules, anatomical segmental lung resection, specimen collection through natural orifices, robotic/laparoscopic radical cystectomy with orthotopic neobladder, and large-segment radiotherapy. Promoted the market approval of domestic original innovative drugs including Utidelone, Darsi-limab, and Fluzoparib.

Key Capabilities & Patient Care

Able to comprehensively carry out surgery, chemotherapy, radiotherapy, interventional therapy, and other methods, with a multidisciplinary standardized comprehensive treatment level leading the nation. Multiple indicators such as the five-year survival rate of treated patients, average length of hospital stay, proportion of grade IV surgeries, and case mix index rank first among specialized cancer hospitals in the country. Entrusted to lead the formulation and revision of 33 oncology single-disease diagnosis and treatment guidelines. As the supporting unit of the National Cancer Registration Center, it organizes the implementation of major public health projects for early diagnosis and treatment of cancer; it has established a national cancer prevention and treatment network led by the National Center with 23 provincial cancer centers as the backbone, and has jointly built national regional oncology medical centers in Liaoning, Shanxi, Henan, Shenzhen, etc., with integrated management of the Langfang campus.

Advanced Technology

Equipped with advanced equipment such as proton accelerators, MRI-guided medical linear accelerators, rotational intensity-modulated radiotherapy linear accelerators, ultra-high-end spectral CT, 3T high-field functional imaging MRI, and PET-MRI. It has 1 national key laboratory (for basic and clinical tumor research), 1 national clinical medical research center, and 2 Beijing key laboratories. Data statistics: • Bed capacity: nearly 2,000 beds (both campuses open, 2026) • Total staff: not disclosed, estimated 4,000–4,500 people • Inpatient volume: estimated 60,000–70,000 cases/year • Outpatient and emergency visits: over 1 million annually (official, 2025 data) • Inpatient and elective surgeries: over 30,000 surgeries per year (official, 2025 data) • Number of senior physicians: official total not disclosed; estimated around 480–640 people (this is an estimate, not official data, based on 4,000 staff × 12%-16% calculation)

International Patient Services

Signed cooperation agreements with the International Agency for Research on Cancer, the Asian National Cancer Centers Alliance, the U.S. National Cancer Institute, and others to build a "Belt and Road" international cooperation network; initiated the establishment of the Asian Thoracic Surgeons Association and founded the all-English journal "Journal of the National Cancer Center." (Did not mention specific services of the independent specialty department/international department)

Return to Home